Home
    • Plans Blog Contact
    LFTD PARTNERS INC. logo

    LFTD PARTNERS INC.

    LIFD
    Last price US$0.2
    Market cap US$3.0m
    12M price change -39.39%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Zoetis IncZTS Industry peer Amphastar PAMPH Industry peer Prestige Consumer HealthcarePBH Industry peer IQVIA Holdings IncIQV Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    LFTD PARTNERS INC. Overview

    Industry: Drug Manufacturers Specialty & Generic

    Sector: Healthcare

    LFTD Partners Inc., through its subsidiary, Lifted Made, manufactures and sells hemp-derived cannabinoid products, and psychoactive and alternative lifestyle products under the Urb Finest Flowers and Silly Shruum brands. It also sells its products through www.Urb.shop website. The company was formerly known as Acquired Sales Corp. and changed its name to LFTD Partners Inc. in September 2021. LFTD Partners Inc. was incorporated in 1986 and is headquartered in Jacksonville, Florida. LFTD Partners Inc., through its subsidiary, Lifted Made, manufactures and sells hemp-derived cannabinoid products, and psychoactive and alternative lifestyle products under the Urb Finest Flowers and Silly Shruum brands. It also sells its products through www.Urb.shop website. The company was former Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for LFTD PARTNERS INC. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed May 15, 2026

    Quarterly result summary

    Latest company-filed earnings material is available for source review.

    What changed

    • Review the SEC source filing for the full reported results and management commentary.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    SEC filing Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing FORM 10-K Apr 01, 2026 SEC filing FORM 10-Q Nov 14, 2025 SEC filing FORM 10-Q Aug 14, 2025 SEC filing FORM 10-Q May 15, 2025 SEC filing FORM 10-K Mar 31, 2025 SEC filing FORM 10-Q Nov 14, 2024 SEC filing FORM 10-Q Aug 14, 2024

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    No qualified company news in the last 14 days

    No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.

    Earnings Per Share

    Score 3.00/5
    LFTD PARTNERS INC. boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Return on Equity

    Score 2.11/5
    LFTD PARTNERS INC. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    LFTD PARTNER... LIFD US$3.0m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 2.51/5
    LFTD PARTNERS INC. commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    LFTD PARTNER... LIFD US$3.0m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Leverage

    Score 3.18/5
    LFTD PARTNERS INC. attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    LFTD PARTNER... LIFD US$3.0m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    LFTD PARTNERS INC. logo

    LFTD PARTNERS INC.

    US$0.2

    US$1.08

    +440.7% vs price

    US$3.0m

    5.26%

    -39.39%